Qingyi Li is a creative Medicinal Chemist and experienced Project Leader with a strong focus on innovative drug discovery and development. As of 2022, they serve as the Executive Director at Eli Lilly and Company, after holding the position of VP of Chemistry at Sanegene Bio from 2021 to 2022. Qingyi's extensive experience includes successful leadership roles at Dicerna Pharmaceuticals, Inc. and Cubist Pharmaceuticals, where they managed teams and advanced multiple drug candidates, particularly in antibacterial and pain therapeutic areas. They earned a Ph.D. in Organic Chemistry from UT Southwestern Medical Center at Dallas in 2008.
This person is not in the org chart
This person is not in any teams
This person is not in any offices